Literature DB >> 23266884

Co-morbidities in heart failure.

Vincent M van Deursen1, Kevin Damman, Peter van der Meer, Peter J Wijkstra, Gert-Jan Luijckx, Andre van Beek, Dirk J van Veldhuisen, Adriaan A Voors.   

Abstract

Heart failure is a clinical syndrome characterized by poor quality of life and high morbidity and mortality. Co-morbidities frequently accompany heart failure and further decrease in both quality of life and clinical outcome. We describe that the prevalence of co-morbidities in patients with heart failure is much higher compared to age-matched controls. We will specifically address the most studied organ-related co-morbidities, that is, renal dysfunction, cerebral dysfunction, anaemia, liver dysfunction, chronic obstructive pulmonary disease, diabetes mellitus and sleep apnoea. The pathophysiologic processes underlying the interaction between heart failure and co-morbid conditions are complex and remain largely unresolved. Although common risk factors are likely to contribute, it is reasonable to believe that factors associated with heart failure might cause other co-morbid conditions. Inflammation, neurohumoral pathway activation and hemodynamic changes are potential factors. We try to provide explanations for the observed association between co-morbidities and heart failure, as well as its impact on survival.

Entities:  

Mesh:

Year:  2014        PMID: 23266884     DOI: 10.1007/s10741-012-9370-7

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  86 in total

1.  Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure.

Authors:  G Zuccalà; C Cattel; E Manes-Gravina; M G Di Niro; A Cocchi; R Bernabei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

2.  Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

Authors:  D L Dries; N K Sweitzer; M H Drazner; L W Stevenson; B J Gersh
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

3.  Abnormal liver function in relation to hemodynamic profile in heart failure patients.

Authors:  V M van Deursen; K Damman; H L Hillege; A P van Beek; D J van Veldhuisen; A A Voors
Journal:  J Card Fail       Date:  2009-09-26       Impact factor: 5.712

Review 4.  Cognitive influences on self-care decision making in persons with heart failure.

Authors:  Victoria V Dickson; Nancy Tkacs; Barbara Riegel
Journal:  Am Heart J       Date:  2007-09       Impact factor: 4.749

5.  Brain magnetic resonance imaging abnormalities in patients with heart failure.

Authors:  Raymond L C Vogels; Wiesje M van der Flier; Barbera van Harten; Alida A Gouw; Philip Scheltens; Jutta M Schroeder-Tanka; Henry C Weinstein
Journal:  Eur J Heart Fail       Date:  2007-08-23       Impact factor: 15.534

Review 6.  Cognitive deficits in patients with heart failure: a review of the literature.

Authors:  Susan J Bennett; Mary Jane Sauvé
Journal:  J Cardiovasc Nurs       Date:  2003 Jul-Aug       Impact factor: 2.083

7.  Hemodilution is common in patients with advanced heart failure.

Authors:  Ana-Silvia Androne; Stuart D Katz; Lars Lund; John LaManca; Alhakam Hudaihed; Katarzyna Hryniewicz; Donna M Mancini
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

8.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

9.  Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics.

Authors:  S H Kubo; B A Walter; D H John; M Clark; R J Cody
Journal:  Arch Intern Med       Date:  1987-07

10.  Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.

Authors:  Kevin Damman; Gerjan Navis; Tom D J Smilde; Adriaan A Voors; Wim van der Bij; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur J Heart Fail       Date:  2007-06-22       Impact factor: 15.534

View more
  16 in total

Review 1.  Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.

Authors:  Iris E Beldhuis; Carolyn S P Lam; Jeffrey M Testani; Adriaan A Voors; Harriette G C Van Spall; Jozine M Ter Maaten; Kevin Damman
Journal:  Circulation       Date:  2022-02-28       Impact factor: 39.918

2.  Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.

Authors:  G Youcef; A Olivier; N Nicot; A Muller; C Deng; C Labat; R Fay; R-M Rodriguez-Guéant; C Leroy; F Jaisser; F Zannad; P Lacolley; L Vallar; A Pizard
Journal:  Br J Pharmacol       Date:  2016-04-26       Impact factor: 8.739

3.  Cardiorenal sodium MRI in small rodents using a quadrature birdcage volume resonator at 9.4 T.

Authors:  Laura Boehmert; Helmar Waiczies; Andre Kuehne; Celal Oezerdem; Sonia Waiczies; Ludger Starke; Min-Chi Ku; Andreas Pohlmann; Erdmann Seeliger; Thoralf Niendorf
Journal:  MAGMA       Date:  2019-12-03       Impact factor: 2.310

Review 4.  Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door.

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2022-05       Impact factor: 4.214

Review 5.  Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis.

Authors:  Natalie McCormick; Diane Lacaille; Vidula Bhole; J Antonio Avina-Zubieta
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

Review 6.  A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis.

Authors:  Sandra Korol; Fannie Mottet; Sylvie Perreault; William L Baker; Michel White; Simon de Denus
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore.

Authors:  Palvinder Kaur; Nakul Saxena; Alex Xiaobin You; Raymond C C Wong; Choon Pin Lim; Seet Yoong Loh; Pradeep Paul George
Journal:  BMJ Open       Date:  2018-05-20       Impact factor: 2.692

8.  Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.

Authors:  Constantinos Ergatoudes; Maria Schaufelberger; Bert Andersson; Aldina Pivodic; Ulf Dahlström; Michael Fu
Journal:  Clin Res Cardiol       Date:  2019-02-20       Impact factor: 5.460

9.  Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers (ENABLE CHF-PC): study protocol for a randomized controlled trial.

Authors:  Rachel Wells; Macy L Stockdill; J Nicholas Dionne-Odom; Deborah Ejem; Kathryn L Burgio; Raegan W Durant; Sally Engler; Andres Azuero; Salpy V Pamboukian; Jose Tallaj; Keith M Swetz; Elizabeth Kvale; Rodney O Tucker; Marie Bakitas
Journal:  Trials       Date:  2018-08-06       Impact factor: 2.279

10.  Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.

Authors:  Ryo Konno; Shunsuke Tatebe; Koichiro Sugimura; Kimio Satoh; Tatsuo Aoki; Masanobu Miura; Hideaki Suzuki; Saori Yamamoto; Haruka Sato; Yosuke Terui; Satoshi Miyata; Osamu Adachi; Masato Kimura; Yoshikatsu Saiki; Hiroaki Shimokawa
Journal:  PLoS One       Date:  2019-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.